GlassScriptPhysician profile
Claudia Phen
NPI 1760876049
$1,351.73
in general payments reported to CMS, 2019-2025
9 companies · $56.30 in 2025
The $56.30 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $206 · 2021: $66.53 · 2022: $39.42 · 2023: $110 · 2024: $150 · 2025: $56.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $586.50 | 2019-2022 | |
| Qol Medical, LLC | $270.43 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $125.23 | 2023-2024 | Dupixent |
| Alexion Pharmaceuticals, INC. | $116.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.61 | 2020-2025 | Gattex |
| Genzyme Corporation | $82.50 | 2023-2024 | |
| Amgen INC. | $22.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.82 | 2020 | |
| Fresenius Kabi USA, LLC | $14.58 | 2023 | Smoflipid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Phen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.